SIRPA and colorectal carcinoma: Transgenic macrophages were specifically expressing Elk-1 regulate TAM phagocytic activity and CRC progression in a SIRPα-dependent manner (Figure 1), providing a potential target for macrophage immunotherapy in CRC patients (96).